Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_assertion type Assertion NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_head.
- NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_assertion description "[Elevated pretreatment levels of hTERT were identified in 80.2% of squamous cell carcinoma and 73.8% of adenocarcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_provenance.
- NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_assertion evidence source_evidence_literature NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_provenance.
- NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_assertion SIO_000772 21319134 NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_provenance.
- NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_assertion wasDerivedFrom befree-20140225 NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_provenance.
- NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_assertion wasGeneratedBy ECO_0000203 NP882274.RAldS5zMEl1rWFoWOCKZD7YGEFm0RpQWq5I7ozg3pff_k130_provenance.